Intracellular Th (ITCI) has had the highest return since January 1, 2025 by a large-cap US stock, returning 51.2%.
| ASSET | % RETURN |
|---|---|
Intracellular Th (ITCI) | 51.15% |
Summit Therapeutics (SMMT) | 30.88% |
Xpeng (XPEV) | 30.42% |
Twilio (TWLO) | 26.87% |
CVS Health (CVS) | 26.17% |
Royalty Pharma (RPRX) | 24.15% |
Robinhood Markets (HOOD) | 23.87% |
BeOne Medicines (ONC) | 23.42% |
Constellation Energy (CEG) | 21.48% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 20.85% |
Carvana (CVNA) | 20.65% |
Synnex (SNX) | 19.76% |
VF (VFC) | 19.6% |
Builders FirstSource (BLDR) | 19.59% |
Guidewire Software (GWRE) | 19.33% |
Futu (FUTU) | 19.31% |
Tamboran Resources (TBN) | 19.05% |
Nu (NU) | 18.8% |
Seagate Technology (STX) | 18.66% |
Ubiquiti Networks (UI) | 18.23% |
Telefonica Brasil SA ADR (VIV) | 18.16% |
JD Inc Adr (JD) | 18.11% |
AngloGold Ashanti (AU) | 18.09% |
UBS (UBS) | 17.89% |
Plains All American Pipeline (PAA) | 17.88% |
Large-cap stocks are treated as having a market cap of $10B+.
